The effect of rutin-N-mustard on the survival of NK/Ly ascites tumour-bearing mice
✍ Scribed by J. Molnár; I. Mucsi; Y. Mándi; I. Béládi; S. Földeák; K. Boda
- Publisher
- John Wiley and Sons
- Year
- 1982
- Tongue
- French
- Weight
- 461 KB
- Volume
- 30
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
A newly synthetized rutin derivative, rutin‐N‐mustard, showed a marked antiproliferative effect on NK/Ly ascites tumour cells in vivo. When administered i.p. or i.v., this compound increased the survival time of the animals, but oral administration had no such effect. The drug was not able to kill the tumour cells, since the chromium release from the rutin‐N‐mustard‐treated tumour cells was the same as in the case of the controls. Tumour growth was completely inhibited in the animals when the cells were pretreated with 100 mg/kg rutin‐N‐mustard before transplantation. The results also showed that rutin‐N‐mustard has little effect on the xenogenization of NK/Ly tumour cells. We presume that the antiproliferative action of rutin‐N‐mustard is due to its alkylating activity.
📜 SIMILAR VOLUMES
The petroleum ether extract of the seeds of carrot (Daucus carota Linn), administered intraperitoneally at doses of 3 mg and 10 mg/kg body weight/day for 7 days, showed antitumour activity, inhibiting the growth of Ehrlich ascites tumour in mice.
## Abstract Phosgene, widely used in industrial processes, can cause life‐threatening pulmonary edema and acute lung injury. One mechanism of protection against phosgene‐induced lung injury may involve the use of antioxidants. The present study focused on dietary supplementation in mice using __n__